Welcome to our dedicated page for Alpha Cognition SEC filings (Ticker: ACOG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Alpha Cognition Inc. (NASDAQ: ACOG) SEC filings page on Stock Titan provides centralized access to the company’s U.S. regulatory disclosures. Alpha Cognition is an emerging growth, commercial-stage biopharmaceutical company focused on Alzheimer’s disease and other neurodegenerative conditions, and its filings offer detailed insight into how it finances, governs, and reports on its ZUNVEYL and ALPHA-1062 programs.
Through this page, users can review Current Reports on Form 8-K that document material events such as public offerings of common shares and pre-funded warrants, at-the-market offering agreements, changes in the independent registered public accounting firm, and adoption of equity incentive plans. For example, recent 8-Ks describe an underwriting agreement for a public offering intended to support ZUNVEYL commercialization, an ATM agreement with a sales agent for up to a specified aggregate amount of common shares, and the transition from a Canada-based auditor to a U.S.-licensed firm following relocation of principal executive offices to Texas.
Investors can also use this page to monitor corporate governance and compensation matters, including shareholder votes on the number of directors, director elections, ratification of auditors, and approval of stock incentive plans, as reported in meeting-related filings. These documents help clarify how Alpha Cognition structures its board, aligns management incentives, and complies with exchange and securities regulations.
Stock Titan enhances these filings with AI-powered summaries that highlight key terms, financial implications, and governance changes, reducing the time needed to interpret lengthy documents. Real-time integration with the SEC’s EDGAR system means new ACOG filings appear promptly, while dedicated sections for material agreements and capital markets activity make it easier to follow offerings, ATM usage, and other financing tools. For users interested in deeper due diligence on Alpha Cognition’s Alzheimer’s-focused business, this page serves as a structured entry point into the company’s official regulatory record.
Opaleye Management Inc., a more than ten percent owner of Alpha Cognition Inc., reported additional open-market purchases of the company’s common stock. Through Opaleye, L.P., it bought 5,708 shares on March 12, 2026 at a weighted average price of $5.8543 per share and 7,358 shares on March 13, 2026 at a weighted average price of $5.7470, for a total of 13,066 shares. After these transactions, Opaleye, L.P. held 2,434,012 shares, and a separately managed account overseen by Opaleye held 90,000 shares, all reported as indirect ownership. The prices reflect multiple trades within narrow ranges, with Opaleye undertaking to provide detailed breakdowns upon request. Opaleye Management disclaims beneficial ownership except to the extent of its pecuniary interest.
Alpha Cognition Inc. large shareholder Opaleye Management Inc., through its fund Opaleye, L.P., reported open-market purchases of 4,079 shares of Common Stock. The buys occurred on March 6 and March 9, 2026 at weighted average prices of
Following these transactions, Opaleye, L.P. held 2,420,946 shares indirectly, and a separately managed account overseen by Opaleye held 90,000 shares. Opaleye Management Inc. states it may be deemed a beneficial owner but disclaims beneficial ownership beyond its pecuniary interest.
Alpha Cognition Inc. insider activity centers on indirect open‑market buying linked to Opaleye entities. Opaleye Management Inc., as investment manager of Opaleye, L.P. and portfolio manager of a separately managed account, may be deemed to beneficially own their holdings but disclaims beneficial ownership beyond its pecuniary interest.
On March 4–5, 2026, Opaleye, L.P. and the managed account purchased a combined 66,818 shares of Alpha Cognition common stock in open‑market transactions. After these trades, Opaleye, L.P. held 2,416,867 shares, and the managed account held 90,000 shares, all reported as indirect ownership.
Alpha Cognition Inc. large shareholder Opaleye Management Inc., through affiliated accounts, reported open-market purchases of a total of 71,411 shares of common stock. The buys occurred on March 2 and March 3, 2026 at weighted average prices of about
Alpha Cognition Inc. amended a Schedule 13G filing to report that Opaleye Management Inc., together with Opaleye, L.P. and James Silverman, beneficially own 2,388,638 common shares, representing
The Adviser (Opaleye Management Inc.) advises the Fund and Mr. Silverman controls the Adviser; shared voting and dispositive power are reported for the aggregate holdings. Signatures are dated
Opaleye Management Inc., as investment manager and portfolio manager for related entities, reported indirect open-market purchases of Alpha Cognition common stock totaling 4,228 shares around
Opaleye Management Inc., a more than ten percent owner of Alpha Cognition Inc., reported indirect open-market purchases of 171,410 shares of common stock. The trades occurred on February 20, 23 and 24, 2026 at weighted average prices around $5.84–$5.89 per share.
Shares were acquired through Opaleye, L.P. and a separately managed account, both reported as indirect holdings. Some purchases were executed in multiple transactions within stated price ranges, and Opaleye Management Inc. disclaims beneficial ownership beyond its pecuniary interest.
Alpha Cognition Inc. reported that director Len Mertz has informed the board that he will not stand for re-election at the company’s 2026 annual meeting. He will continue to serve as a board member until that meeting, when his current term expires.
The company stated that Mr. Mertz’s decision is not due to any disagreement with Alpha Cognition regarding its operations, policies, or practices. The filing focuses solely on this planned board transition and does not announce other business or financial changes.
Alpha Cognition Inc. had an amended insider ownership report filed by Opaleye Management Inc., a more than ten percent owner. The filing shows indirect holdings of 2,125,000 shares of common stock through Opaleye, L.P. and 68,589 shares through a managed account. Opaleye Management Inc. disclaims beneficial ownership of these shares except to the extent of its pecuniary interest.
Alpha Cognition Inc. ownership update: Opaleye Management Inc., Opaleye, L.P. and James Silverman report shared beneficial ownership of 2,193,589 common shares, equal to 10.09% of the class. The filing states the Adviser has shared voting and dispositive power and cites